🚚 FREE U.S. Shipping on Orders Over $500
SKU: CJC-1295_IPA_5/5mg

CJC-1295 (no DAC) / IPAMORELIN Blend

This product contains two synthetic peptides in a single lyophilized preparation.

CJC-1295 without DAC, also designated Modified GRF (1-29), is a 29-residue analogue of the N-terminal fragment of growth hormone-releasing hormone (GHRH 1-29). It carries four amino acid substitutions relative to the native fragment, which reduce susceptibility to enzymatic cleavage, and a C-terminal amide. It does not carry the Drug Affinity Complex linker found in the DAC version.

Ipamorelin is a synthetic pentapeptide, Aib-His-D-2-Nal-D-Phe-Lys-NH₂, containing the unnatural residues alpha-aminoisobutyric acid and 2-naphthylalanine, two D-amino acid substitutions, and a C-terminal amide. In published literature it has been characterized as a ligand of the growth hormone secretagogue receptor subtype 1a (GHS-R1a), distinguished within its class by reported selectivity for that receptor.

This material is supplied as a characterized reference preparation for non-clinical laboratory work, such as analytical method development and separation of multi-peptide preparations, GHRH receptor and GHS-R1a binding assays, comparative receptor selectivity profiling, and somatotroph cell culture assays.

Compound Specifications

Property CJC-1295 (no DAC) Ipamorelin
Other designations Modified GRF (1-29), Mod GRF 1-29 —
Sequence length 29 residues 5 residues
Sequence [supply from COA] Aib-His-D-2-Nal-D-Phe-Lys-NH₂
Molecular formula [see note below] C₃₈H₄₉N₉O₅
Molecular weight ~3368 g/mol [verify] ~711.9 g/mol
CAS number 863288-34-0 [see note] 170851-70-4

Storage & Handling
Store lyophilized powder at −20 °C, protected from light. Avoid moisture and repeated freeze-thaw cycles. Handle in accordance with standard laboratory safety practices.

FOR RESEARCH USE ONLY. Not for human consumption. Not intended for human or veterinary use. For laboratory research and analytical purposes only.

$95.00

Choose Quantity

Description

This product contains two synthetic peptides in a single lyophilized preparation.

CJC-1295 without DAC, also designated Modified GRF (1-29), is a 29-residue analogue of the N-terminal fragment of growth hormone-releasing hormone (GHRH 1-29). It carries four amino acid substitutions relative to the native fragment, which reduce susceptibility to enzymatic cleavage, and a C-terminal amide. It does not carry the Drug Affinity Complex linker found in the DAC version.

Ipamorelin is a synthetic pentapeptide, Aib-His-D-2-Nal-D-Phe-Lys-NH₂, containing the unnatural residues alpha-aminoisobutyric acid and 2-naphthylalanine, two D-amino acid substitutions, and a C-terminal amide. In published literature it has been characterized as a ligand of the growth hormone secretagogue receptor subtype 1a (GHS-R1a), distinguished within its class by reported selectivity for that receptor.

This material is supplied as a characterized reference preparation for non-clinical laboratory work, such as analytical method development and separation of multi-peptide preparations, GHRH receptor and GHS-R1a binding assays, comparative receptor selectivity profiling, and somatotroph cell culture assays.

Compound Specifications

Property CJC-1295 (no DAC) Ipamorelin
Other designations Modified GRF (1-29), Mod GRF 1-29 —
Sequence length 29 residues 5 residues
Sequence [supply from COA] Aib-His-D-2-Nal-D-Phe-Lys-NH₂
Molecular formula [see note below] C₃₈H₄₉N₉O₅
Molecular weight ~3368 g/mol [verify] ~711.9 g/mol
CAS number 863288-34-0 [see note] 170851-70-4

Storage & Handling
Store lyophilized powder at −20 °C, protected from light. Avoid moisture and repeated freeze-thaw cycles. Handle in accordance with standard laboratory safety practices.

FOR RESEARCH USE ONLY. Not for human consumption. Not intended for human or veterinary use. For laboratory research and analytical purposes only.

Additional information

Weight 0.1 lbs
Dimensions 1 × 1 × 2 in

Disclaimer: For Research Purposes Only

This content is supplied exclusively for research and educational purposes. Nothing presented here should be interpreted as approval, promotion, or encouragement of any non-laboratory use, improper handling, or non-research application of peptides intended for scientific investigation. Any references to specific peptides, their properties, or findings associated with them are provided solely as informational research content. This information does not constitute legal advice, clinical guidance, or a recommendation for personal, therapeutic, or non-research use. These compounds are intended only for controlled scientific work conducted by qualified and authorized individuals. Before making any decision regarding the purchase, possession, handling, or use of research peptides, consultation with qualified research professionals or legal counsel is strongly advised. All information should be used responsibly, ethically, and only in connection with legitimate academic, scientific, or investigative purposes. This notice applies broadly to all peptide-related content provided here and may be updated as needed.

0